NYSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 05/29/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization949,705 mln
Float889 mln
Earnings Date08/05/2026
EPS
28.12
Exceptional
P / E
39.31
Overvalued
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-1.67
Likely manipulated
1-Year Forecast
1,211
Modest upside
Relative Strength
93
/ 100
Top performer
Business Description
Founded in 1876 and based in Indianapolis, Indiana, Eli Lilly and Company is a global pharmaceutical company that researches, produces, and sells medicines across the United States, Europe, Asia, and beyond. Its product portfolio spans several major health areas, including diabetes and weight management, cancer treatment, immune system disorders, and neurological conditions such as migraines and Alzheimer's disease. The company also works alongside partners like Boehringer Ingelheim, Roche, and Genentech to bring additional treatments to market.
